Nutrition throughout life: Folate

International Journal for Vitamin and Nutrition Research

Volumn 82, Issue 5, 2012, Pages 348-354

  McNulty, Helene ^a   Pentiev, Kristina ^a   Hoey, Leane ^a   Strain, J J ^a   Ward, Mary ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Cardiovascular disease (CVD); Folate; Folic acid; Neural tube defects (NTD); Personalised medicine

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; LIVER EXTRACT; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); RIBOFLAVIN;

AGING; ALCOHOLISM; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CANCER PREVENTION; CARBON METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELIAC DISEASE; CEREBROVASCULAR ACCIDENT; COGNITION; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FETUS DEVELOPMENT; FOLIC ACID DEFICIENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEART DISEASE; HOMOZYGOTE; HUMAN; HYPERTENSION; LIFE CYCLE; LOW DRUG DOSE; MACROCYTIC ANEMIA; MALABSORPTION; MATERNAL WELFARE; MEGALOBLASTIC ANEMIA; METHYLATION; NEURAL TUBE DEFECT; NUTRITION; OPTIMAL DRUG DOSE; PERSONALIZED MEDICINE; PREGNANCY; PREGNANCY OUTCOME; YEAST;

BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; DRUG STABILITY; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; NEURAL TUBE DEFECTS; NUTRITION POLICY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; PREGNANCY;

EID: 84880620296     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000130     Document Type: Article

References (32)

1. Shane, B. (2010) Folate chemistry and metabolism. In: Folate in Health and Disease, 2nd ed. (Bailey, L. B., ed.) pp.1-24, CRC Press, Taylor and Francis Group, Boca Raton.
2. Bailey, R. L., Mills, J. L., Yetley, E. A., Gahche, J. J., Pfeiffer, C. M., Dwyer, J. T., Dodd, K. W., Sempos, C. T., Betz, J. M., and Picciano, M. F. (2010). Unmetabolized Serum Folic Acid and Its Relation to Folic Acid Intake from Diet and Supplements in a Nationally Representative Sample of Adults Aged = 60 Y in the United States. Am. J. Clin. Nutr. 92, 383-89.
3. Chanarin, I. (1985). Folate and cobalamin. Clin. Haematol. 14, 629-641.
4. Wills, L. (1931) Treatment of 'pernicious anaemia of pregnancy' and 'tropical anaemia' with special reference to yeast extract as a curative agent. Brit. Med. J. 1, 1059-1064.
5. Tamura, T., Picciano, M. F. and McGuire, M. K. (2010) Folate in pregnancy and lactation. In: Folate in Health and Disease, 2nd ed. (Bailey, L. B., ed.) pp.111-131, CRC Press, Taylor and Francis Group, Boca Raton.
6. Stabler, S. P. (2010) Clinical folate defi ciency. In: Folate in Health and Disease, 2nd ed. (Bailey, L.B., ed.) pp.409-428, CRC Press, Taylor and Francis Group, Boca Raton.
7. Dickey, W., Ward, M., Whittle, C., Kelly, M., Pentieva, K., Horigan, G., Patton, S. and McNulty, H. (2008) Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery. Scand. J. Gastroenterol. 43, 682-688.
8. Halsted, C. H., Medici, V. and Esfandiari, F. (2010) Infl uence of alcohol on folate status and methionine metabolism in relation to alcoholic liver disease. In: Folate in Health and Disease, 2nd ed. (Bailey, L. B., ed.) pp.429-448, CRC Press, Taylor and Francis Group, Boca Raton.
9. McNulty, H. and Pentieva, K. (2010) Folate bioavailability. In: Folate in Health and Disease, 2nd ed. (Bailey, L. B., ed.) pp.25-47, CRC Press, Taylor and Francis Group, Boca Raton.
10. Vollset, S. E., Refsum, H., Irgens, L. M., Emblem, B. M., Tverdal, A., Gjessing, H. K., Monsen, A. L. and Ueland, P. M. (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 71, 962-968.
11. Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T. and Satoh, K. (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke. JAMA- J. Am. Med. Assoc. 293 (9), 1082-1088.
12. Durga, J., van Boxtel, M. P., Schouten, E. G., Kok, F. J., Jolles, J., Katan, M. B. and Verhoef, P. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369 (9557), 208-216.
13. Saposnik, G., Ray, J. G., Sheridan, P., McQueen, M. and Lonn, E. (2009) Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability Additional Findings From the HOPE 2 Trial. Stroke 40 (4), 1365-1372.
14. Ray, J. G., Singh, G., Burrows, R. F. (2004) Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG- Int. J. Gynecol. Obstet. 111, 399-408.
15. McNulty, B., Pentieva, K., Marshall, B., Ward, M., Molloy, A. M., Scott, J. M. and McNulty, H. (2011) Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Human Reprod. 26 (6), 1530-1536.
16. Botto, L. D., Lisi, A., Robert-Gnansia, E., Erickson, J. D., Vollset, S. E., Mastroiacovo, P., Botting, B., Cocchi, G., de Vigan, C., de Walle, H., Feijoo, M., Irgens, L. M., McDonnell, B., Merlob, P., Ritvanen, A., Scarano, G., Siffel, C., Metneki, J., Stoll, C., Smithells, R. and Goujard, J. (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? Brit. Med. J. 330 (7491), 571-573.
17. Honein, M. A., Paulozzi, L. J., Mathews, T. J., Erickson, J. D. and Wong, L. Y. C. (2001) Impact of folic acid fortifi cation of the US food supply on the occurrence of neural tube defects. JAMA- J. Am. Med. Assoc. 285 (23), 2981-2986.
18. De Wals, P., Tairou, F., Van Allen, M. I., Uh, S.-H., Lowry, R. B., Sibbald, B., Evans, J. A., Van den Hof, M. C., Zimmer, P., Crowley, M., Fernandez, B., Lee, N. S. and Niyonsenga, T. (2007) Reduction in neuraltube defects after folic acid fortifi cation in Canada. New Engl. J. Med. 357 (2), 135-142.
19. The Homocysteine Studies, C. and Clarke, R. (2002) Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA- J. Am. Med. Assoc. 288 (16), 2015-2022.
20. Wald, D. S., Law, M. and Morris, J. K. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Brit. Med. J. 325 (7374), 1202-1206.
21. McNulty, H., Strain, J. J., Pentieva, K. and Ward, M. (2012) C-1 metabolism and CVD outcomes in older adults. P. Nutr. Soc. 71 (2), 213-221.
22. Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, Y., Sun, N., Liu, L. and Xu, X. (2007) Effi cacy of folic acid supplementation in stroke prevention: a metaanalysis. Lancet 369 (9576), 1876-1882.
23. Lee, M., Hong, K.-S., Chang, S.-C. and Saver, J. L. (2010) Effi cacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention A Meta-Analysis. Stroke 41 (6), 1205-1212.
24. Mason, J. B. (2011) Folate consumption and cancer risk: a confi rmation and some reassurance, but we're not out of the woods quite yet. Am. J. Clin. Nutr. 94, 936-964.
25. Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., Schouten, E. G. and Grp, M. S. C. (2002) MTHFR 677C → T polymorphism and risk of coronary heart disease-A meta-analysis. JAMA- J. Am. Med. Assoc. 288 (16), 2023-2031.
26. Holmes, M. V., Newcombe, P., Hubacek, J. A., Sofat, R., Ricketts, S. L., Cooper, J., Breteler, M. M. B., Bautista, L. E., Sharma, P., Whittaker, J. C., Smeeth, L., Fowkes, F. G. R., Algra, A., Shmeleva, V., Szolnoki, Z., Roest, M., Linnebank, M., Zacho, J., Nalls, M. A., Singleton, A. B., Ferrucci, L., Hardy, J., Worrall, B. B., Rich, S. S., Matarin, M., Norman, P. E., Flicker, L., Almeida, O. P., van Bockxmeer, F. M., Shimokata, H., Khaw, K.-T., Wareham, N. J., Bobak, M., Sterne, J. A. C., Smith, G. D., Talmud, P. J., van Duijn, C., Humphries, S. E., Price, J. F., Ebrahim, S., Lawlor, D. A., Hankey, G. J., Meschia, J. F., Sandhu, M. S., Hingorani, A. D. and Casas, J. P. (2011) Effect modifi cation by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet 378 (9791), 584-594.
27. Wilson, C. P., Ward, M., McNulty, H., Strain, J. J., Trouton, T. G., Horigan, G., Purvis, J. and Scott, J. M. (2012) Ribofl avin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. Am. J. Clin. Nutr. 95 (3), 766-772.
28. McNulty, H., Dowey, L. R. C., Strain, J. J., Dunne, A., Ward, M., Molloy, A. M., McAnena, L. B., Hughes, J. P., Hannon-Fletcher, M. and Scott, J. M. (2006) Ribofl avin lowers homocysteine in individuals homozygous for the MTHFR 677C → T polymorphism. Circulation 113 (1), 74-80.
29. Hoey, L., McNulty, H., Askin, N., Dunne, A., Ward, M., Pentieva, K., Strain, J. J., Molloy, A. M., Flynn, C. A. and Scott, J. M. (2007) Effect of a voluntary food fortifi cation policy on folate, related B vitamin sta tus, and homocysteine in healthy adults. Am. J. Clin. Nutr. 86 (5), 1405-1413.
30. Cuskelly, G. J., McNulty, H. and Scott, J. M. (1996) Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet 347 (9002), 657-659.
31. Yang, Q. H., Botto, L. D., Erickson, J. D., Berry, R. J., Sambell, C., Johansen, H. and Friedman, J. M. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113 (10), 1335-1343.
32. Tighe, P., Ward, M., McNulty, H., Finnegan, O., Dunne, A., Strain, J. J., Molloy, A. M., Duffy, M., Pentieva, K. and Scott, J. M. (2011) A dose-fi nding trial of the effect of long-term folic acid intervention: implications for food fortifi cation policy. Am. J. Clin. Nutr. 93 (1), 11-1.